The
nanoparticle vaccine
technology used in the study has been licensed by Parvus Therapeutics, Inc., a biotechnology company arising from the University Technology International LP, the technology transfer and commercialization center for the University o
technology used in the study has been licensed by Parvus
Therapeutics, Inc., a biotechnology company arising from the University
Technology International LP, the technology transfer and commercialization center for the University o
Technology International LP, the
technology transfer and commercialization center for the University o
technology transfer and commercialization center for the University of Calgary.